首页|期刊导航|中国免疫学杂志|CD14+CD277+单核-巨噬细胞、T细胞上PD-1的表达对ARDS患儿呼吸支持治疗临床转归的预测

CD14+CD277+单核-巨噬细胞、T细胞上PD-1的表达对ARDS患儿呼吸支持治疗临床转归的预测OA北大核心CSTPCD

Expression of CD14+CD277+monocyte macrophage and PD-1 on T cells predict clinical outcome of respiratory support therapy in children with ARDS

中文摘要英文摘要

目的:探讨CD14+CD277+单核-巨噬细胞、T细胞上程序性死亡受体1(PD-1)的表达对呼吸支持治疗的急性呼吸窘迫综合征(ARDS)患儿临床转归的预测价值.方法:回顾分析2014年4月至2020年3月三二〇一医院新生儿科130例ARDS患儿的临床资料.患儿治疗28 d后,根据患儿存活状态,将其分为存活组和死亡组,比较两组患儿治疗前CD14+CD277+单核-巨噬细胞、T细胞上PD-1水平,分析影响患儿结局的独立危险因素及CD14+CD277+单核-巨噬细胞、T细胞上PD-1水平预测患儿死亡的价值.结果:死亡组CD14+CD277+单核-巨噬细胞比例和PD-1平均荧光浓度(MFI)高于存活组(P<0.05).多因素Logistics回归分析显示,胎龄、低白蛋白血症、出生5 min的Apgar评分、CD14+CD277+单核-巨噬细胞、T细胞数PD-1表达均属于ARDS死亡的独立危险因素(P<0.05).CD14+CD277+单核-巨噬细胞预测患儿死亡的ROC曲线下面积为0.777(95%CI:0.698~0.855,P=0.000),预测死亡的截断值为0.105%,灵敏度和特异度为81.96%和55.67%.T细胞上PD-1预测患儿死亡的ROC曲线下面积为0.756(95%CI:0.674~0.838,P=0.000),预测死亡的截断值为114 MFI,灵敏度和特异度为80.45%和58.23%.结论:CD14+CD277+单核-巨噬细胞、T细胞上PD-1水平与ARDS新生儿的预后有关,其水平较高,表明预后不佳,死亡风险较高.

Objective:To investigate the predictive value of the expression of CD14+CD277+monocyte macrophage and pro-grammed death receptor-1(PD-1)on T cells in clinical outcome of children with acute respiratory distress syndrome(ARDS).Meth-ods:The clinical data of 130 children with ARDS in 3201 hospital from April 2014 to March 2020 were respectively analyzed.After 28 days of treatment,the children were divided into survival group and death group according to their survival status.The levels of PD-1 on CD14+CD277+monocyte macrophages and T cells in survival group and death group were compared.The independent risk factors af-fecting the outcome of the children and the value of PD-1 levels on CD14+CD277+monocyte-macrophages and T cells in predicting the death of the children were analyzed.Results:The proportion of CD14+CD277+monocyte-macrophages and MFI in the death group were higher than those in the survival group(P<0.05).Multivariate Logistic regression analysis showed that gestational age,Apgar score at 5 min after birth,hypoalbuminemia,CD14+CD277+monocyte macrophage and PD-1 on T cells were independent risk factors for death(P<0.05).The area under the ROC curve of CD14+CD277+monocyte macrophage was 0.777(95%CI:0.698~0.855,P=0.000),the cut-off value was 0.105%,the corresponding sensitivity was 81.96%,and the specificity was 55.67%.The area under ROC curve of PD-1 on T cells was 0.756(95%CI:0.674~0.838,P=0.000),and the cutoff value for predicting death was 114 MFI.The sensitivity and specificity were 80.45%and 58.23%.Conclusion:The level of PD-1 on CD14+CD277+monocyte-macrophages and T cells is relat-ed to the prognosis of neonates with ARDS,and its higher level indicates poor prognosis and a higher risk of death.

张冬梅;王来栓;应海燕

通用医疗三二〇一医院新生儿科,汉中 723000上海市复旦大学附属儿科医院新生儿科,闵行 201102

临床医学

急性呼吸窘迫综合征CD14+CD277+单核-巨噬细胞T细胞上程序性死亡受体1预后

Acute respiratory distress syndromeCD14+CD277+Monocyte-macrophageProgrammed death receptor 1Prog-nosis

《中国免疫学杂志》 2024 (012)

2609-2613,2622 / 6

国家重点研发计划项目(2017YFA0104202).

10.3969/j.issn.1000-484X.2024.12.025

评论